INCY
Incyte Corporation
NASDAQ · USHealthcareBiotechnology
$115.65-1.36%
Price as of Jul 20, 2026
INCY valuation
Incyte Corporation valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 13.76x
- P/E 2026E
- 15.29x
- P/E 2027E
- 12.71x
- P/E 2028E
- 11.79x
- P/S forward
- 3.97x
Trailing multiples
- P/E TTM
- 15.84x
- PEG TTM
- 1.05x
- Price / book
- 4.16x
- Price / sales
- 4.31x
- Price / cash flow
- 15.23x
Enterprise value
- Enterprise value
- $19.1B
- EV / sales
- 3.57x
- EV / EBITDA
- 10.22x
- EV / EBIT
- 13.19x
- Market cap
- $23.1B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.